Ceftobiprole
Ceftobiprole (Ro 63-9141) is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci with a MIC90 value of 2 μg/mL for MRSA. Ceftobiprole also inhibits gram-positive and gram-negative pathogens. Ceftobiprole can be used for the study of hospital-acquired pneumonia (excluding ventilator-associated pneumonia) and community-acquired pneumonia[1][2][3].
Product Specifications
CAS Number
[209467-52-7]
Product Name Alternative
Ro 63-9141; BAL 9141
UNSPSC
12352005
Hazard Statement
H302, H312, H332
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Ceftobiprole.html
Purity
97.22
Solubility
DMSO : 4.95 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C(N12)=C(/C=C3C(N([C@H]4CNCC4)CC/3)=O)CS[C@]2([H])[C@H](NC(/C(C5=NSC(N)=N5)=N\O)=O)C1=O)O
Molecular Formula
C20H22N8O6S2
Molecular Weight
534.57
Precautions
H302, H312, H332
References & Citations
Staphylococcus aureusStaphylococcus aureus
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
β-lactam
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Pax5/BSAP Antibody (PAX5/2595) [DyLight 755]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
RAB25, ID (RAB25, CATX8, Ras-related protein Rab-25, CATX-8) (MaxLight 550)